By Mariam Sunny Jan 26 (Reuters) - Sarepta Therapeutics' gene therapy for Duchenne muscular dystrophy slowed disease ...
News-Medical.Net on MSN
Minimally invasive biopsy enables real-time tracking of amyloid disease progression
Transthyretin amyloidosis (ATTR) is a rare, progressive and highly aggressive degenerative disease. It is caused by the ...
Measurable residual disease-guided ibrutinib-venetoclax therapy achieved undetectable disease in bone marrow in 66.2% of patients with chronic lymphocytic leukemia (CLL) within 2 years compared with ...
Communicating effectively with other specialists on the care team is essential, says Aaron T. Gerds, MD, MS, Associate Professor of Medicine at Cleveland Clinic Lerner College of Medicine of Case ...
In metastatic cancer surveillance, monitoring the actual concentrations of circulating tumor DNA (ctDNA) may be critical. Researchers showed that absolute ctDNA concentration thresholds can be defined ...
Elizabeth Cooney is a cardiovascular disease reporter at STAT, covering heart, stroke, and metabolic conditions. You can reach Liz on Signal at LizC.22. Right now, patients with obesity and cirrhosis ...
Jan 26 (Reuters) - Sarepta Therapeutics' gene therapy for a muscle‑wasting disorder slowed disease progression and showed sustained benefit in patients' ability to control and coordinate movement ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results